Quick Answer
Eloxx Pharmaceuticals, Inc. reported Total Revenue of $0.00 for fiscal year 2025.
Eloxx Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $6.36M | — |
| 2023 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2012 | $0.00 | -100.0% | -100.0% |
| December 31, 2011 | $200.0K | — | — |
- Eloxx Pharmaceuticals, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Eloxx Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: